大孔树脂富集三裂叶蟛蜞菊倍半萜内酯A和B的研究

目的 大量富集三裂叶蟛蜞菊倍半萜内酯A，B(WTA，WTB)。方法 采用气相色谱法测定WTA和WTB，并以WTA和WTB的含量、洗脱率、精制度为考察指标，研究D101大孔树脂吸附WTA和WTB的工艺条件及参数。结果 通过大孔树脂吸附后，WTA和WTB的洗脱率达90％，50％乙醇洗脱部分中WTA和WTB的含量为总固物的4．01％～4．09％。结论 可以采用大孔树脂富集WTA和WTB。     

HZ818树脂在紫杉醇初分离工艺中的应用

采用HZ818大孔吸附树脂对红豆杉浸膏中的紫杉醇成分进行吸附和洗脱试验，同时利用液质联用进行分析检测，确定了其最佳工艺参数。结果表明，HZ818树脂对紫杉醇有良好的吸附分离效果。优化工艺条件为：样品溶于体积分数40％甲醇，以1．5mL／min过柱，体积分数75％甲醇淋洗，体积分数85％甲醇以0．5mL／min洗脱，紫杉醇的质量分数从原浸膏中的1．02％提高到8．1％，回收率达98．6％。     

多官能度活性橡胶增韧环氧树脂的研究：Ⅲ.三元共混增韧环氧树脂

本文研究了双酚A对多官能度环氧基和羧基聚丙烯酸正丁酯橡胶增韧环氧树脂的影响。结果表明,加入双酚A,拉伸断裂能有大幅度提高,同时不降低弹性模量。这可能是由椽胶提高断裂伸长与双酚A提高屈服应力产生协同效应的结果。对羧基橡胶增韧的三元共混体系,拉伸断裂能随羧基官能度上升而增加。断裂面的形态研究表明,由于羧基橡胶与双酚A的酯化反应,大大减少了羧基橡胶聚集对增韧的不利影响。     

橡胶活性官能团对增韧环氧树脂动态力学性能的影响

用动态扭摆法测试聚丙烯酸丁酯橡胶增韧环氧树脂的动态力学行为,研究在环氧树脂低固化度和高固化度时,橡胶活性官能团种类(环氧基官能团与羧基官能团)和数量(官能度)对其影响。研究体系中橡胶玻璃化转变温度(Tg)的移动大小,与橡胶和基体树脂健合程度之间的关系。     

Distribution of calbindin D-28K and parvalbumin immunoreactivities in the nucleus olfactorius anterior of the rat

The distributions of calbindin D-28K (CaBP) and parvalbumin (PV) in the rat nucleus olfactorius anterior (NOA) were described using monoclonal antibodies and the avidin-biotin-peroxidase method. The NOA showed a high immunoreactivity for CaBP, with a rostrocaudal increase in the positive neurons and fibres. Pars externa (NOAe) was the only subdivision which showed a low CaBP immunostaining. PV-positive elements were less abundant than those CaBP immunostained. The main difference in the distributions for both proteins was observed in the pars medialis which was practically PV negative. PV- and CaBP-stained neurons showed similar morphologies in the subdivisions where they were present. In NOAe, we observed a characteristic PV- and CaBP-positive neuronal type, with an oriented dendritic pattern. Transition areas were clearly observable in both CaBP- and PV-labelled sections.     

新型粘结固定桥临床应用初步观察

目的 观察一种用于牙列缺损永久修复的新型粘结固定桥的临床效果。方法 选择有单个或多个牙缺失的病人，进行固定桥基牙的牙周和特定的牙体预备。然后制作固定桥并试戴，用4－META／MMA－TBB树脂粘结剂粘结固定桥。结果 267例（304个）固定桥病人经二年以上随访，发现192个前牙桥中只有1个，112个后牙桥中只有2个脱落，其余固定桥稳定、功能良好。结论 采用树脂粘接技术，结合基牙的机械预备，能较好地克服3／4冠桥、桩冠桥和嵌体桥的缺陷，使之成为良好永久的修复体。     

胜利黄岛原油深度电脱盐的研究：Ⅰ.破乳剂组成的影响

根据胜利黄岛原油的性质，在筛选了几十种破乳剂的基础上，选择了酚醛树脂和环氧环烷，环氧乙烷的嵌段共聚物作破乳剂，探讨了破乳剂组成对原油脱水，脱盐以及界面张力的影响，通过静态脱盐，脱水试验，得到了适合黄岛原油的最佳破乳剂组成。     

Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons

The effects of the D-1 agonist SKF 38393 on tonic activity of rat substantia nigra pars compacta dopamine neurons were studied using extracellular, single-unit recording techniques. Unlike nonselective D-1/D-2 dopamine agonists or the D-2 agonist quinpirole, SKF 38393 did not inhibit dopamine neuronal activity when applied iontophoretically or when administered intravenously in doses up to 20 mg/kg to chloral hydrate-anesthetized rats. Moreover, pretreatment with SKF 38393 did not alter the inhibitory response of these neurons to apomorphine or the D-2 agonist quinpirole. However, in locally anesthetized, gallamine-treated, artificially respired rats, dopamine cell activity was significantly altered by i.v. administration of SKF 38393; firing rate increases and decreases were observed. Administration of the inactive enantiomer of SKF 38393, S-SKF 38393, did not induce similar changes in parallel experiments. These results support the idea that unlike D-2 autoreceptor stimulation, D-1 receptor stimulation does not exert a direct local effect on dopamine neurons in the substantia nigra pars compacta and suggest that D-1 receptor stimulation at sites postsynaptic to the dopamine cells may indirectly affect the activity of some dopamine neurons through long-loop feedback mechanisms.     

Radium-228 determination of natural waters via concentration on manganese dioxide and separation using Diphonix ion exchange resin

The objective of this work was to establish a new procedure for ²²⁸Ra determination of natural waters via preconcentration of radium on MnO₂ and separation of its daughter, ²²⁸Ac, using Diphonix ion exchange resin. Following removal of potential interferences via passage through an initial Diphonix Resin column, the first daughter of ²²⁸Ra, ²²⁸Ac, is isolated by chromatographic separation via a second Diphonix column. A holding time of >30 h for ²²⁸Ac ingrowth in between the two column separations ensures secular equilibrium. Barium-133 is used as a yield tracer. Actinium-228 is eluted from the second Diphonix Resin with 5 ml 1 M 1-Hydroxyethane-1,1-diphosphonic acid (HEDPA) and quantified by addition of scintillation cocktail and LSC counting. Radium (and ¹³³Ba) from the load and rinse solutions from the 2nd Diphonix column may be prepared for alpha spectrometry (for determination of ²²³Ra, ²²⁴Ra, and ²²⁶Ra) by BaSO₄ microprecipitation and filtration. Decontamination tests indicate that U, Th, and Ra series nuclides do not interfere with these measurements, although high contents of ⁹⁰Sr (⁹⁰Y) require additional treatment for accurate measurement of ²²⁸Ra. Addition of stable Sr as a “hold back” carrier during the initial MnO₂ preconcentration step was shown to remove most ⁹⁰Sr interference.     

In vivo receptor binding,neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390

Summary A series of in vivo experiments were undertaken, relating functional (motor activity, body temperature), dopamine (DA) receptor binding and neurochemical (catecholamine synthesis and utilization, DA release) aspects of the pharmacology of SCH 23390 in the rat.The compound inhibited the locomotor hyperactivity, but not the hypothermia, induced by the potent DA stimulant DP-5,6-ADTN. Interstingly, SCH 23390 simultaneously failed to displace DP-5,6-ADTN from its binding sites in the rat striatum—used as a direct in vivo biochemical index of DA (D-2) receptor interaction. The spontaneous locomotion in non-pretreated rats was likewise inhibited by SCH 23390. The locomotor-suppressive action, but not the DP-5,6-ADTN-displacing capcity of the D-2 blocker haloperidol was significantly enhanced by SCH 23390, suggesting that motility can be suppressed by either enhanced D-1 or D-2 (postsynaptic) receptor blockade, but also that the D-1 and D-2 sites involved may be physically distinct.SCH 23390 only slightly altered in vivo neurochemical of DA synthesis, release and nerve-impulse flow, indicating that, while similar in suppressing dopaminergic behaviour, the D-1 antagonist is less effective than traditional neuroleptics as an activator of DA neuronal feedback mechanisms. The weak increases of DA synthesis and release nonetheless obtained were equal in magnitude (30–40%) in the limbic vs. striatal brain areas; also in this respect, SCH 23390 thus differs from classical neuroleptics, which generally display more marked effects in the striatum than in limbic tissue.No major changes in the in vivo indices of NA synthesis and utilization (or in 5-HT synthesis) were found after SCH 23390 administration, by and large supporting the DA receptor specificity of the compound.In summary, the studies demonstrated that SCH 23390 can offset and accentuate, respectively, behavioural consequences of D-2 receptor stimulation and blockade. Importantly, at the same time no direct interaction at the level of D-2 DA receptor sites in the striatum was detected. Only slight, D-2 antagonist-like, changes in neurochemical indices of dopaminergic activity were observed after D-1 receptor blockade by means of SCH 23390. With regard to DA agonist hypothermia, SCH 23390 was without effect per se, but (at a high dose) attenuated the action of the D-2 antagonist haloperidol. The observations may indicate that the complex interactions between central D-1 and D-2 receptor-controlled mechanisms that influence behaviour, neurochemistry, and possibly autonomic nervous expression, are not identical.